Actual Medicinal Product (AMP) Sitagliptin 50mg / Metformin 850mg tablets (Alliance Healthcare (Distribution) Ltd)

Stability Information

(Some stability information inherited from generic)

Stability
compatible_special_measures logo Lack of data and/or stability concerns exist. MCA use may be acceptable but is likely to be off-label and require mitigation measures. Keep medicines in MCAs for the shortest time necessary. Generally, up to 5 weeks maximum unless otherwise specified, or up to 8 weeks if the MCA is airtight (sealed). Consider the risk of potency loss or dose variability and monitor for changes in efficacy or adverse effects after MCA initiation.
Notes

Original packaging may contain desiccant. No stability data in MCAs available.

Provenance

This recommendation is based on the product Sitagliptin/Metformin 50mg/850mg film-coated tablets (Glenmark Pharmaceuticals Europe Ltd)

Generic
Sitagliptin + Metformin
Formulation
Sitagliptin 50mg / Metformin 850mg tablets
  • Sitagliptin + Metformin
    • Sitagliptin 50mg / Metformin 850mg tablets

      • Sitagliptin 50mg / Metformin 850mg tablets (Alliance Healthcare (Distribution) Ltd)